Physician
Amed Medical Group PLLC
Amed Medical Group PLLC was paid $1.65M by Medicaid between Jan 2020 and Dec 2024, across 40 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 45% of everything it billed.
33Billing provider infoAMED MEDICAL GROUP PLLC
NASHVILLE, TN 37211
NASHVILLE, TN 37211
33aNPI1952956500assigned 08/09/2019
33bProvider typeFamily Medicine Physician
28Total paid$1.65M
24GClaims58,882
24DCodes billed40
24AFirst – last monthJan 2020 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Tennessee
Rank by total paid#38 of 754
Median peer was paid$34K
This provider vs. median49×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 3,173 | $105K | |
| 2021 | 12,269 | $409K | |
| 2022 | 13,812 | $413K | |
| 2023 | 15,839 | $371K | |
| 2024incomplete | 13,789 | $347K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 45% | 14,183 | 11,433 | $747K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 10,233 | 8,614 | $368K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.8% | 3,068 | 2,479 | $145K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.1% | 2,390 | 1,980 | $133K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 3.6% | 1,776 | 1,590 | $60K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.0% | 4,129 | 3,332 | $50K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.5% | 2,811 | 2,239 | $41K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.4% | 3,105 | 2,329 | $40K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 2,590 | 2,279 | $21K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 110 | 91 | $7K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 75 | 59 | $6K |
| 96127 | <1% | 1,653 | 1,294 | $5K |
28 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 3,192 | $5K |
| 81002 | <1% | 2,661 | $4K | |
| 81000 | <1% | 1,937 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 30 | $2K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 167 | $2K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,069 | $1K |
| 0001A | <1% | 30 | $1K | |
| 92570 | <1% | 58 | $1K | |
| 0002A | <1% | 25 | $1K | |
| 99173 | <1% | 260 | $830.22 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 18 | $473.90 |
| 82962 | <1% | 317 | $473.52 | |
| 0053A | <1% | 18 | $440.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 27 | $409.09 |
| 90686 | <1% | 19 | $237.84 | |
| 93000 | <1% | 15 | $224.24 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 14 | $211.43 |
| 81025 | <1% | 52 | $187.69 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 709 | $145.10 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 19 | $141.88 |
| 91300 | 0% | 160 | $0.00 | |
| 1160F | 0% | 735 | $0.00 | |
| 3078F | 0% | 22 | $0.00 | |
| 1159F | 0% | 32 | $0.00 | |
| 1126F | 0% | 624 | $0.00 | |
| 1125F | 0% | 464 | $0.00 | |
| 91305 | 0% | 52 | $0.00 | |
| 3074F | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialABDULLAH, DILMON (PROVIDER/SECRETARY/ORGANIZER)